首页 | 本学科首页   官方微博 | 高级检索  
     检索      

Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture
作者姓名:JINWeiwu  HULiangxiang  DUZhenglin  GAOQiang  GAOHong  NINGYe  FENGJidong  ZHANGJiansan  YINWeidong  LINing
作者单位:[1]StateKeyLaboratoryforAgrobiotechnology,ChinaAgriculturalUniversity,Beijing100094,China [2]SinoBiotechCo.,Ltd.,No.39ShangdiXiRd.HaidianDistrict,Beijing100085,China
摘    要:SARS coronavirus is an RNA virus whose replication is error-prone, which provides possibility for escape of host defenses, and even leads to evolution of new viral strains during the passage or the transmission. Lots of variations have been detected among different SARS-CoV strains. And a study on these variations is helpful for development of efficient vaccine. Moreover, the test of nucleic acid characterization and genetic stability of SARS-CoV is important in the research of inactivated vaccine. The whole genome sequences of two SARS coronavirus strains after passage in Vero cell culture were determined and were compared with those of early passages, respectively. Results showed that both SAPS coronavirus strains have high genetic stability, although nearly 10 generations were passed. Four nucleotide variations were observed between the second passage and the llth passage of Sinol strain for identification of SARS inactivated vaccine. Moreover, only one nucleotide was different between the third passage and the 10th passage of Sino3 strain for SARS inactivated vaccine. Therefore, this study suggested it was possible to develop inactivated vaccine against SARS-CoV in the future.

关 键 词:基因组序列  变量分析  SARS  冠状病毒  疫苗  SARS-CoV  非典型肺炎
收稿时间:2004-05-15
修稿时间:2004-07-24

Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture
JINWeiwu HULiangxiang DUZhenglin GAOQiang GAOHong NINGYe FENGJidong ZHANGJiansan YINWeidong LINing.Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture[J].Chinese Science Bulletin,2004,49(17):1824-1827.
Authors:Weiwu?Jin  Liangxiang?Hu  Zhenglin?Du  Qiang?Gao  Hong?Gao  Ye?Ning  Jidong?Feng  Jiansan?Zhang  Weidong?Yin  Email author" target="_blank">Ning?LiEmail author
Institution:JIN Weiwu1,HU Liangxiang2,DU Zhenglin1,GAO Qiang2,GAO Hong2,NING Ye2,FENG Jidong1,ZHANG Jiansan2,YIN Weidong2 & LI Ning1 1.State Key Laboratory for Agrobiotechnology,China Agricultural University,Beijing 100094,China 2.Sino Biotech Co.,Ltd.,No.39 Shangdi Xi Rd.Haidian District,Bei- jing 100085,China
Abstract:SARS coronavirus is an RNA virus whose rep- lication is error-prone, which provides possibility for escape of host defenses, and even leads to evolution of new viral strains during the passage or the transmission. Lots of varia- tions have been detected among different SARS-CoV strains. And a study on these variations is helpful for development of efficient vaccine. Moreover, the test of nucleic acid characterization and genetic stability of SARS-CoV is im- portant in the research of inactivated vaccine. The whole genome sequences of two SARS coronavirus strains after passage in Vero cell culture were determined and were com- pared with those of early passages, respectively. Results showed that both SARS coronavirus strains have high ge- netic stability, although nearly 10 generations were passed. Four nucleotide variations were observed between the sec- ond passage and the 11th passage of Sino1 strain for identi- fication of SARS inactivated vaccine. Moreover, only one nucleotide was different between the third passage and the 10th passage of Sino3 strain for SARS inactivated vaccine. Therefore, this study suggested it was possible to develop inactivated vaccine against SARS-CoV in the future.
Keywords:severe acute respiratory syndrome (SARS)  SARS Coro- navirus (SARS-CoV)  virus  vaccine  
本文献已被 CNKI 维普 万方数据 SpringerLink 等数据库收录!
点击此处可从《中国科学通报(英文版)》浏览原始摘要信息
点击此处可从《中国科学通报(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号